- Titre
- Toward the end of a controversy on the effect of reduction in brain amyloid levels on change in cognitive and functional decline in Alzheimer's disease-Reply to a letter
- Créateurs - sans rôle
- Menglan Pang - Biogen, Biogen Digital Hlth, Cambridge, MA USALing Zhu - Biogen, Biogen Digital Hlth, Cambridge, MA USAAudrey Gabelle - Biogen, Biogen Digital Hlth, Cambridge, MA USAArie R. Gafson - Biogen, Biogen Digital Hlth, Cambridge, MA USARobert W. Platt - McGill UniversityJames E. Galvin - Univ Miami, Comprehens Ctr Brain Hlth, Dept Neurol, Miller Sch Med, Boca Raton, FL USAPierre Krolak-Salmon - Hosp Civils Lyon, Lyon Inst Aging, Clin & Res Memory Ctr Lyon CMRR Lyon, Univ Hosp Lyon, Lyon, FranceIvana Rubino - Biogen, Cambridge, MA USACarl de Moor - Biogen, Biogen Digital Hlth, Cambridge, MA USAShibeshih Belachew - Biogen, Biogen Digital Hlth, Cambridge, MA USAChangyu Shen - Biogen, Biogen Digital Hlth, Cambridge, MA USA
- Détails de publication
- Alzheimer's & dementia, Vol.19(3), pp.1101-1103
- Éditeur
- Wiley
- Nombre de pages
- 3
- Identifiants
- 99139850109311
- Unité académique
- Institut des Neurosciences de Montpellier - INM
- Langue
- English
- Type de ressource
- Journal article
Article de revue
Toward the end of a controversy on the effect of reduction in brain amyloid levels on change in cognitive and functional decline in Alzheimer's disease-Reply to a letter
Alzheimer's & dementia, Vol.19(3), pp.1101-1103
03/2023
PMID: 36383475
Indicateurs
1 Consultations de la notice